Non-alcoholic fatty liver disease ... in real life, as reflected by the emergence of new acronyms, such as BASH and BAFLD for ‘both’ ALD and NAFLD. Histopathological studies in obese or patients with ...

1). That suggests HepaStem could act on the mechanisms of cirrhosis, fibrosis, and control the acute and sub chronic inflammation that respectively contributes to ACLF and NASH. These are major ...